The Bill & Melinda Gates Foundation is accepting applications for Round 13 of its Grand Challenges Explorations initiative, an accelerated grant program that encourages bold approaches aimed at improving the lives of the world’s poorest people. Anyone — students, scientists, entrepreneurs — with a transformative idea is invited to apply.
Initial grants of $100,000 are awarded twice a year, and successful projects have the opportunity to receive a follow-on grant of up to $1 million. The five topics for Grand Challenges Explorations Round 13 are measuring fetal and infant brain mortality, integrating community-based interventions, inciting health behaviors, diarrhea and enteric dysfunctions, and innovations for building agricultural development programs.
Since its launch in 2008, the program has funded more than nine hundred grants in over fifty countries. The program welcomes proposals from a broad spectrum of contributors and encourages cross-disciplinary approaches. The Gates Foundation and an independent group of reviewers will select the most innovative proposals, and grants will be awarded within approximately four months of the proposal submission deadline.
The PhRMA Foundation is accepting proposals for “starter grants” in support of research aimed at quantifying the benefits to society that have accrued from innovations in cancer treatment.
The grant will be awarded to candidates who establish a sound and innovative research project focused on developing a novel way of quantifying or describing the social, patient-centered, and economic benefits of innovation in cancer treatment. Relevant research goals may include developing new methods to define and measure the societal benefits from cancer care innovation. For example, this could include contributing to an understanding of value across a wider range of outputs that can be more difficult to assess, capturing heterogeneity in patient values (such as quality of life, productivity, etc.) within and among populations, and accounting for variability in value over time and its relationship to long-term aggregate clinical gains against cancer.
This award is not intended for clinical or bench research, and is focused on supporting research in the health economics and social science fields. Additionally, research results should be generalizable to the context of the United States. Proposals focused on methods are eligible; however, researchers must clearly indicate how these new methods will be used to capture patient, population, or societal outcomes and benefits.
The award consists of $100,000 for one year and is made to the university or institution on behalf of the recipient, with the understanding that the university or institution will administer the funds. The “starter” aspect of the program strives to assist individuals who are establishing careers as independent investigators with an interest in describing the benefits of cancer treatment, innovation, and progress. The funds are to be used to conduct the proposed research and provide the grantee with financial support to promote future research efforts in this field.
Individuals holding the rank of instructor, assistant professor, or investigator at the doctoral level are eligible to apply.